Alzheimer's Drug Discovery Foundation
| Founders | Leonard A. Lauder, Ronald S. Lauder, and Dr. Howard Fillit |
|---|---|
| Focus | The mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the development of drugs to prevent, treat and cure Alzheimer's disease. |
| Location |
|
| Website | Official website |
The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by co-chairmen Leonard A. Lauder and Ronald S. Lauder of the Estée Lauder Companies cosmetics family and led by Howard Fillit, a geriatrician and neuroscientist. The ADDF provides funding to scientists who are conducting promising, innovative Alzheimer's disease drug research worldwide. The ADDF funds early-stage research and early-phase clinical trials that might otherwise go unfunded. By supporting research projects around the world, it seeks to increase the chances of finding treatments for Alzheimer's disease, related dementias and cognitive aging. The ADDF has invested nearly $65 million to fund some 450 Alzheimer's drug discovery programs and clinical trials in academic centers and biotechnology companies in 18 countries.